The 66th ASMS Conference on Mass Spectrometry and Allied Topics of the American Society for Mass Spectrometry took place in San Diego from June 2nd to June 7th.
Before the actual conference, Bing Peng and Robert Ahrends participated in the Skyline User Group meeting
and presented the latest advances in LipidCreator, a Skyline plugin for targeted lipidomics.
Members of LIFS and the associated Lipidomics groups were present at the main conference with a diverse number of posters and presentations:
Posters:
MP 469 Proposal for a common nomenclature for fragment ions in mass spectra of lipids
Josch K Pauling [1]; Martin Hermansson [1]; Peter Husen [1]; Jürgen Hartler [2]; Sandra F. Gallego [1]; Bing Peng [3]; Robert Ahrends [3]; Christer Ejsing* [1] [4]
[1] University of Southern Denmark, Odense, Denmark; [2] Graz University of Technology, Graz, Austria; [3] ISAS, Dortmund, Germany; [4] EMBL, Heidelberg, Heidelberg, Germany
Bing Peng [1]; Sascha Geue [2]; Cristina Coman [1]; Dominik Kopczynski [1]; Patrick Münzer [2]; Albert Sickmann [1]; Meinrad Gawaz [2]; Oliver Borst [2]; Robert Ahrends* [1]
[1] ISAS, Dortmund, Germany; [2] Department of Cardiology and Cardiovascular Medicine, Tuebingen, Germany
WP 511 Laser capture microdissection coupled with shotgun profiling reveals full-lipidome zonation in liver
Olga Vvedenskaya*; Oskar Knittelfelder; Sofia Traikov; Andrej Shevchenko
Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany
WP 520 LipidCreator: A new bridge between targeted and non-targeted LC-MS/MS-based lipidomics
Bing Peng* [1]; Dominik Kopczynski [1]; Nils Hoffmann [1]; Brian Pratt [2]; Dominik Schwudke [3]; Christer S. Ejsing [4] [5]; Brendan MacLean [2]; Robert Ahrends [1]
[1] ISAS, Dortmund, Germany; [2] University of Washington Genome Sciences, Seattle, WA; [3] Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany; [4] University of Southern Denmark, Odense, Denmark; [5] Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany
Oral presentations:
Guidelines for Lipidomics Analysis and Reporting – the Lipidomics Standards Initiative (LSI)
Gerhard Liebisch* [1]; John A. Bowden [2]; William J. Griffiths [3]; Robert Ahrends [4]; Todd W Mitchell [5]; Makoto Arita [6]; Christer Ejsing [7]; Michal Holčapek [8]; Markus R. Wenk [9]; Kim Ekroos [10]
[1] Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg, Germany; [2] Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, USA, Charleston, SC; [3] Swansea University Medical School, ILS1 Building, Singleton Park, Swansea, United Kingdom; [4] Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany; [5] School of Medicine, Illawarra Health and Medical Research Institute, University of Wollongong, NSW 2522, Wollongong, Australia; [6] Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences (IMS), Tsurumi, Kanagawa 230-0045, Yokohama, Japan; [7] Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, DK-5230, Odense, Denmark; [8] Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic; [9] Singapore Lipidomics Incubator (SLING), Department of Biochemistry, YLL School of Medicine, National University of Singapore, Singapore, Singapore; [10] Lipidomics Consulting Ltd., FI-02230, Esbo, Finland
